Bavarian Nordic announces that the consortium consisting of Nordic Capital and Permira has withdrawn its takeover offer to the shareholders following preliminary results. Read more.
Bio-Works Technologies receives orders for WorkBeads 40S to contract manufacturers in Europe. Read more.
Brain+ provides update. Read more.
Coegin introduces a new customized complementary product – Follicopeptide – with launch planned for early 2026. Read more.
Embla Medical expands its support for Ukrainian amputees by opening a new clinic in Kiev and initiating a partnership in Iceland. Read more.
Gubra reports record revenue and revises forecast for CRO operations. Read more.
IRLAB gets two abstracts accepted to AD/PD 2026: The 20th International Conference on Alzheimer's and Parkinson's Diseases. Read more.
Magnasense completes the sale of its subsidiaries. Read more. The company also completes the reverse acquisition of Subgen AI. Read more.
Novo Nordisk announces an agreement with the U.S. government to make GLP-1 drugs available to more Americans at a lower cost. Read more.
PolarCool announces that PolarCap is being used by the England men's national rugby league team. Read more.
Scandinavian Real Heart publishes the board's complete proposal for a new share issue. Read more.
SciBase and Castle Biosciences expands collaboration and licensing agreements and enters into a loan agreement of SEK 20 million. Read more.
Scibase The board of directors decides on an offer to repurchase outstanding warrants of series TO 2 and intends to decide on a rights issue of shares of approximately SEK 83 million. Read more.
Spago Nanomedical publishes information documents in connection with an upcoming rights issue. Read more.
VibroSense Dynamics announces delayed deliveries to China. Read more.
Insider trading & whistleblowing
Invitations & presentations
Acarix ALK Abello Arctic Bioscience Egetis Therapeutics Nose Plugs Zealand Pharma
Communiqués
Reports
Bio Works Technologies ChemoMetec Genmab Genovese Gubra Nose Plugs PExA Perpetua Medical RaySearch Scibase ViroGates
Nomination committees
The latest from BioStock
» Thor Medical comments on the Telix agreement
» Xintela reports clinical progress and strengthens collaborations
» Moberg Pharma comments on the license agreement with Karo Healthcare
» Vesper Bio reports promising results in Phase Ib/IIa
» Pila Pharma stands out in next-generation obesity pipeline
» Enzymatica’s CEO steps down after four years – summarizes a journey from science to commercialization